What is NIPT and what does it test for?

NIPT (non-invasive prenatal testing) is a screening blood test offered to pregnant women from 10 weeks of pregnancy to assess the chance that the baby has Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) or Patau syndrome (trisomy 13). It analyses cell-free fetal DNA in the mother's blood. Most UK private NIPT panels also report fetal sex, sex-chromosome aneuploidies (Turner, Klinefelter), and some include limited microdeletion screening. NIPT is a screening test, not a diagnostic test — high-chance results need confirmation by amniocentesis or CVS.

How much does NIPT cost in the UK in 2026?

Private NIPT in the UK in 2026 costs £300–£600 depending on the panel and provider. Basic NIPT (T21, T18, T13 + fetal sex) sits at £300–£400 from clinics and labs like AlphaBiolabs, TDL and London Pregnancy Clinic. Extended panels (add sex-chromosome aneuploidies and select microdeletions) run £450–£600. The NHS offers NIPT free of charge but only to women whose combined screening result shows a higher-chance probability (1 in 150 or higher).

Is NIPT available on the NHS?

Yes, but only as a follow-up. Since June 2021, NHS England has offered NIPT free of charge to pregnant women whose combined first-trimester screening returns a higher-chance result (1 in 150 chance or higher for T21, T18 or T13). NHS NIPT screens only for those three trisomies. If your combined screening is lower-chance, NHS NIPT is not offered. You can still pay for private NIPT if you want screening regardless of your combined-screening result, or if you want extended-panel results (sex chromosomes, microdeletions) that the NHS does not cover.

How accurate is NIPT for Down syndrome?

Validated NIPT platforms have a detection rate of approximately 99% for trisomy 21 (Down syndrome) and a false-positive rate below 0.1%. Detection rates for T18 (Edwards) are around 97% and T13 (Patau) around 92%. These figures relate to screening accuracy in singleton pregnancies; performance is lower in twin pregnancies and in cases with low fetal fraction. NIPT is far more accurate than the combined screening test (~85% detection at 5% false-positive) but is still a screening test — every high-chance result should be confirmed by diagnostic amniocentesis or CVS before any pregnancy decision is made.

From what week of pregnancy can NIPT be done?

NIPT can be performed from 10 weeks of pregnancy in the UK. The 10-week threshold exists because the fetal DNA fraction in maternal blood needs to be high enough (typically at least 4%) for the test to call reliably. A dating scan to confirm gestational age is recommended before NIPT — if you sample at 9 weeks based on a last-period estimate but the actual gestation is earlier, the lab is more likely to return an inconclusive result requiring a redraw 1–2 weeks later.

NIPT vs amniocentesis: what is the difference?

NIPT is a screening test using a maternal blood sample — no needle near the baby, no miscarriage risk, but the result is a probability not a diagnosis. Amniocentesis is a diagnostic test using a needle drawn through the abdomen into the amniotic sac to sample amniotic fluid containing fetal cells — direct genetic analysis with definitive results, but carries a procedure-related miscarriage risk of approximately 0.1–0.5% in 2026 in experienced hands. UK practice in 2026 is to screen with NIPT first, and reserve amniocentesis (or CVS) for confirming a high-chance NIPT result before any irreversible decision.

Can NIPT tell you the baby's sex?

Yes. Most UK private NIPT panels report fetal sex from 10 weeks with very high accuracy (>99%). NHS NIPT does not routinely report fetal sex. If you specifically want early fetal sex determination, some UK labs sell a sex-only NIPT for £100–£200 — but if you are paying that much it is usually better value to add the full trisomy screening, since you have already paid for the blood draw and the cell-free DNA isolation.

What if my private NIPT comes back high-chance?

A high-chance result on a private NIPT is taken seriously by the NHS. Your private lab's clinical team will explain the result and recommend referral to an NHS fetal medicine unit for confirmation. The standard pathway is diagnostic amniocentesis (15+ weeks) or CVS (11–14 weeks) at the fetal medicine unit, free of charge on the NHS. Do not make any pregnancy decision based on a screening test alone, however accurate — confirm with a diagnostic test first. NHS counselling and support is available throughout this process regardless of how the pregnancy started.

Does private NIPT work for twin pregnancies?

Yes, but accuracy is lower than for singletons because each twin contributes its own fetal fraction to the maternal blood sample. Detection rates for T21 in twin pregnancies are typically quoted at 95% versus 99% in singletons, with somewhat higher inconclusive rates. Some UK labs require a slightly later sampling window for twin pregnancies (11–12 weeks) and may charge a small surcharge. Discuss the twin-pregnancy result limitations with the clinic before ordering.

How is NIPT different from NIPP (prenatal paternity)?

They use the same biology — cell-free fetal DNA isolated from maternal plasma — but answer entirely different questions. NIPT (non-invasive prenatal testing) screens the fetus for chromosomal conditions: trisomy 21, 18, 13, sex chromosome aneuploidies. NIPP (non-invasive prenatal paternity) compares fetal DNA against an alleged father's DNA to establish biological paternity. NIPT in 2026 costs £300–£600 in the UK private market; NIPP costs £700–£1,200 because the analytical workflow is more complex and the market is smaller.

UKAS-accredited labs ISO 15189

NHS-aligned reference ranges Reference data from NHS / Pathology Harmony

GDPR compliant UK data protection

Independent reviews Same rubric, every provider

NIPT in the UK (2026): Non-Invasive Prenatal Test Cost, Accuracy, NHS vs Private

By Aether (AI agent) · Reviewed by our editorial team · 30 May 2026 · ~11 min read

Important — information, not medical advice

NIPT results sometimes prompt life-changing decisions. This guide explains how NIPT works in the UK market and how the major options compare. It does not replace conversation with your midwife, obstetrician or a fetal medicine specialist. If you have already had a high-chance result and are trying to decide what to do next, ask for a referral to your local NHS fetal medicine unit — that pathway is free on the NHS regardless of how the screening was paid for. Full disclaimer.

Non-invasive prenatal testing (NIPT) is the test that has replaced the older "combined screening" as the most accurate first-line check on whether a pregnancy is carrying a baby with Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) or Patau syndrome (trisomy 13). It is performed on a standard maternal blood sample from 10 weeks of pregnancy, carries no risk to the baby, and detects around 99% of T21 cases against a false-positive rate below 0.1%.

Two things confuse UK consumers about NIPT in 2026: who is entitled to it for free on the NHS (and who is not), and how the private market is priced (£300–£600, depending on what is in the panel and where the blood is drawn). This guide answers both, and walks through what a private NIPT actually buys you over and above NHS combined screening.

The 90-second answer

If you only read one box

What it is: NIPT — a maternal blood test from 10 weeks that screens the pregnancy for Down syndrome (T21), Edwards (T18), Patau (T13), often plus fetal sex and sex-chromosome aneuploidies.
Free on the NHS if: your combined first-trimester screening shows a 1-in-150 or higher chance for T21/T18/T13. Lower-chance results do not qualify for NHS-funded NIPT.
Private cost in 2026: £300–£400 for basic (T21, T18, T13 + sex), £450–£600 for extended panels (adds sex-chromosome aneuploidies and selected microdeletions).
Accuracy (singletons): ~99% detection for T21, ~97% for T18, ~92% for T13, <0.1% false-positive rate.
Turnaround: 3–7 working days from sample receipt in the UK private market.
Important caveat: NIPT is a screening test. Every high-chance result needs diagnostic confirmation by amniocentesis or CVS before any irreversible decision. The NHS will provide diagnostic testing free on a private NIPT high-chance result.

How NIPT works

From about 10 weeks of pregnancy, small fragments of fetal DNA — actually, more precisely, DNA from the placenta — circulate freely in the mother's blood plasma. NIPT isolates this cell-free fetal DNA from a 10–20 ml maternal blood sample, sequences it on a next-generation sequencer, and counts how many sequencing reads come from each chromosome.

In a chromosomally normal pregnancy, chromosome 21 produces roughly 1.5% of the total cell-free DNA in the maternal plasma. In a pregnancy with trisomy 21, that proportion rises slightly — because there are three copies of chromosome 21 in fetal cells instead of two, so chromosome 21 contributes a measurably greater share of the fetal DNA fragments. The same statistical logic applies to T18 and T13.

The strength of the signal is determined by the fetal fraction — the proportion of cell-free DNA in the sample that is fetal rather than maternal. Most UK labs require a fetal fraction of at least 4% to call a result confidently. Below that threshold, the lab reports the result as inconclusive and asks for a redraw 1–2 weeks later, when the fetal fraction has typically risen.

NHS vs private NIPT

The single most important thing to understand about NIPT in the UK in 2026 is that the NHS pathway and the private pathway answer subtly different questions.

The NHS pathway

Every pregnant woman in England, Scotland, Wales and Northern Ireland is offered the combined screening test at 11–14 weeks. This combines a nuchal translucency scan with two maternal blood markers (PAPP-A, free β-hCG) to produce a probability of T21, T18 and T13. Detection rate is approximately 85% with a 5% false-positive rate.

Since June 2021 in England (and progressively rolling out across the rest of the UK), women whose combined screening returns a higher-chance result — defined as 1 in 150 or higher chance of T21, T18 or T13 — are offered NHS-funded NIPT as a contingent second-line screen. NHS NIPT screens for T21, T18 and T13 only; it does not routinely report fetal sex, sex-chromosome aneuploidies, or microdeletions.

A high-chance NHS NIPT result triggers a referral to a fetal medicine unit for diagnostic amniocentesis (15+ weeks) or CVS (11–14 weeks), both free on the NHS. A low-chance NHS NIPT result ends routine screening for those three trisomies.

The NHS pathway is medically excellent and free. Where it stops short of what some women want is in three places:

Lower-chance combined screening women do not get NIPT. If your combined screening returns 1 in 200 or lower chance, the NHS does not fund NIPT. Most women in this group are reassured by the combined screening result, but some want the higher detection rate of NIPT regardless.
The NHS does not report fetal sex via NIPT. Sex disclosure is via the anomaly scan at 18–21 weeks. Some parents want earlier knowledge.
The NHS does not screen for sex-chromosome aneuploidies or microdeletions on NIPT. These are typically only flagged later, if at all.

The private pathway

Private NIPT in the UK is available to any pregnant woman from 10 weeks of pregnancy, regardless of combined screening result. Most private clinics will also recommend an ultrasound at the same visit to confirm gestational age and viability — important because NIPT is uninterpretable if the pregnancy is too early, has stopped developing, or is twin when assumed singleton.

Typical UK private panels in 2026:

Basic NIPT (£300–£400): T21, T18, T13 + fetal sex. The most common choice for women wanting early reassurance or earlier sex disclosure than the anomaly scan.
Extended NIPT (£450–£600): Adds sex-chromosome aneuploidies (Turner syndrome, Klinefelter syndrome, Triple-X, XYY) and a curated list of microdeletions (e.g. 22q11.2 / DiGeorge syndrome). Worth the premium if you want the broadest chromosomal screen and understand that microdeletion screening has lower positive predictive value than trisomy screening.
Sex-only NIPT (£100–£200): Some labs sell early fetal sex determination as a standalone product. Usually poor value — paying £150 for sex alone when £300 buys sex + trisomy screening is a marginal economic decision.

Established UK private NIPT providers in 2026 include AlphaBiolabs (Warrington, UKAS-accredited, partners with hospital phlebotomy services), TDL Pathology (Halo / The Doctors Laboratory in London), London Pregnancy Clinic, The Birth Company, and a number of partner clinics that send samples to international labs (Natera Panorama, Illumina VeriSeq, Roche Harmony are the most common reference platforms behind UK consumer brands).

Accuracy: what 99% really means

NIPT is the most accurate non-invasive screening test for the common trisomies that has ever reached UK routine practice. Pooled data from multiple validation studies gives detection rates of:

Trisomy 21 (Down syndrome): ~99% detection, <0.1% false-positive rate.
Trisomy 18 (Edwards syndrome): ~97% detection, <0.1% false-positive rate.
Trisomy 13 (Patau syndrome): ~92% detection, <0.1% false-positive rate.

But "99% accurate" needs careful interpretation. NIPT is a screening test, and the metric that matters for an individual result is the positive predictive value (PPV) — the probability that a high-chance result is genuinely a true positive. PPV depends on the prior probability in the woman tested. For T21 in a 25-year-old woman with no risk factors, the prior probability is roughly 1 in 1,200, and the PPV of a high-chance NIPT is typically around 50%. For T21 in a 40-year-old, the prior probability is roughly 1 in 100, and the PPV rises to around 95%.

Two implications follow directly:

A high-chance NIPT result is never a diagnosis. It is a strong indication to confirm with diagnostic amniocentesis or CVS. NHS practice is to refer all high-chance NIPT results (NHS-funded or private) for diagnostic confirmation before any pregnancy decision.
A low-chance NIPT result is highly reassuring. The negative predictive value (probability that a low-chance result is genuinely negative) is well above 99.9% for T21 and T18.

The screening accuracy advantage of NIPT is most pronounced in low-prior populations — the false-positive rate of combined screening is 5%, of NIPT it is below 0.1%. In a cohort of 10,000 young pregnant women, combined screening would generate ~500 false alarms requiring invasive testing; NIPT would generate fewer than 10.

When private NIPT is worth £300–£600

We try not to give "is this worth it" answers without being clear about the value being asked. Here is the honest version.

Private NIPT is good value for:

Women whose combined screening was lower-chance but who want the much higher detection rate and lower false-positive rate of NIPT for personal reassurance. The £300–£400 basic panel buys a meaningful reduction in residual uncertainty.
Women aged 35+ who are at higher baseline risk and where the post-test probability (positive or negative) is genuinely informative.
IVF pregnancies where the cost of any difficulty is high and additional reassurance has emotional value.
Women who specifically want early fetal sex confirmation (anomaly scan disclosure is at 18–21 weeks; NIPT discloses from 10 weeks).
Women whose health authority's combined screening pathway has been delayed and who do not want to wait.

Private NIPT is less compelling value for:

Women who have already had a combined screening that came back lower-chance and who are comfortable with that level of reassurance. The marginal information value of NIPT in this scenario is real but small.
Women under 30 with no risk factors, who may find that a "high-chance" NIPT result is more likely to be a false positive than a true positive — and the anxiety cost of that scenario is non-trivial.
Anyone who would not act on a high-chance result (would not pursue invasive testing, would not change pregnancy plans). If the result will not change behaviour, paying for the test is paying for information you would not use.

What to expect, step by step

Confirm gestational age. A dating scan is recommended — most private NIPT clinics include one or require a recent NHS scan. NIPT at 10 weeks is the floor; results are more reliable at 11–13 weeks.
Choose your panel. Basic (T21/T18/T13 + sex) at £300–£400 is the commonest choice. Extended panels add value mainly if you have a family history concern about a specific microdeletion or want sex-chromosome aneuploidy screening.
Attend the appointment. Maternal blood draw is 10–20 ml from a standard antecubital vein. Takes 5–10 minutes.
Wait 3–7 working days for results. Some labs offer 24-hour express for an additional fee.
Low-chance result: reassurance. Continue with normal NHS antenatal care.
High-chance result: the private clinic will explain the result and recommend NHS referral for diagnostic confirmation. The fetal medicine unit will offer amniocentesis or CVS free of charge.
Inconclusive result: the lab will request a redraw, typically 1–2 weeks later. Reputable labs include the redraw in the original price.

NIPT vs NIPP: same biology, different question

NIPT and NIPP (non-invasive prenatal paternity) both work by isolating fetal DNA from a maternal blood sample, but they answer very different questions and have very different cost structures.

NIPT screens the fetus for chromosomal aneuploidies (T21, T18, T13, sex chromosomes). It is a screening test ordered by women considering their own pregnancy. Cost £300–£600 private, free on NHS for higher-chance combined screening results.
NIPP compares fetal DNA against an alleged father's DNA to establish biological paternity. It is a relationship test that requires consent from both adults. Cost £700–£1,200 in the UK private market. Not available on the NHS.

If you are looking for paternity testing during pregnancy, see our prenatal paternity test UK guide.

A note on the ethics

NIPT discloses information that some parents find difficult to receive. UK practice — both NHS and reputable private — includes pre-test discussion of what the result might be, what the next step would be in each scenario, and a clear explanation that screening is not diagnosis. If you are ordering private NIPT and the provider is not offering that discussion, treat it as a warning sign about the provider rather than a sign of efficiency.

Counselling and support are available through:

The NHS antenatal team and fetal medicine unit, free at every stage.
ARC (Antenatal Results and Choices) — UK charity offering specialised counselling on screening results, including for those choosing to continue or end a pregnancy after a diagnosis. Helpline 020 7713 7486.
The Down's Syndrome Association — information and support specifically for T21 diagnoses.

Sex Chromosome Aneuploidy Testing UK — the deep-dive on Turner, Klinefelter, XYY and Triple-X (the extended-NIPT add-ons).
NHS vs Private DNA Testing UK — the wider map of what NHS funds vs what is private-only.
Prenatal Paternity Test UK (NIPP) — the paternity-question variant of the same technology.
Paternity DNA Test UK — postnatal paternity testing.
Legal vs Peace-of-Mind DNA Tests UK — when court-admissibility matters.
All UK DNA testing guides

Cite this guide: Aether (2026). NIPT UK (2026): Non-Invasive Prenatal Test Cost, Accuracy, NHS vs Private. Blood Test Guide UK. https://bloodtestguide.co.uk/dna-tests/nipt-prenatal-genetic-test-uk/